Sio Gene Therapies Information
Contact top employees from
Sio Gene Therapies
Summary
Sio Gene Therapies is a private company that has been in the industry for 11 years. The company currently specializes in the Biotechnology area. The Sio Gene Therapies annual revenue is estimated at < 1M. Total funding of the company - $370M. To connect with Sio Gene Therapies employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
neuroscience, neurology, gene therapy, Parkinson's Disease, ALS
Founded
2014
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2014 | Privately Held | 25 - 100 | 3.6M | $50.8M | |
| 2004 | Public Company | 100 - 250 | 31.9M | $133.2M | |
| 2015 | Privately Held | 1 - 25 | < 1M | $0 | |
| 2011 | Privately Held | 10-50 | - | $- | |
| 2013 | Public Company | 100-200 | - | $- | |
| - | Privately Held | 200-500 | - | $- |
Employees Turnover 2 quarter 2025
Length of Employment
Employee tenure at Sio Gene Therapies shows a diverse range of experience levels:
18% for 3–4 years41% for 5–7 years35% for 8–10 years6% have over 11 years of service at Sio Gene TherapiesContact top employees from
Sio Gene Therapies
Kipp Hansen
Associate Director GCP/GLP Quality Assurance
Mathew Bazley
General Counsel
Emily Hughes
Human Resources Generalist
Steve Mohr
General Counsel
Raquel Crystal
Vice President, Head of Human Resources & Operations
Mary Jo Waddell
Senior Clinical Research Liaison
Gladys Noi
Clinical Data Coordinator
Mark Wadley
Senior Vice President of US Business
Robert Jahr
Vice President of Sales Axovant Sciences
Emily Englehart
Talent Acquisition Specialist
Jennifer Levine
Clinical Community Outreach Coordinator
Vivek Ramaswamy
Board Member
Tony Vernon
Board Member
Roger Jeffs
Member Board Of Directors (Public Company)
George Bickerstaff
Board Director
Ghazala Kabani
Director, Clinical Operations
Elimor Brand
Senior Director, Clinical Research
Ryan McHenry
Director, External Reporting and Technical Accounting
Kevin Nash
Postdoctoral Fellow - Nonclinical Pharmacology
Jennifer Pappadakis
VP, Global Medical Affairs & Patient Advocacy
Katie St Ledger
Director, Clinical Research
Amin Bhatt
Associate Director Clinical Operations
Thomas Templeman
Senior Vice President, Pharmaceutical Operations and Quality Assurance
Ashley Seragusa
Clinical Data Coordinator
Renee Hearty
Executive Administrator
Similar Companies
FAQ
Sio Gene Therapies operates in the Biotechnology industries. More details can be found on the official website: siogtx.com.
The headquarters of Sio Gene Therapies are located in New York, United States.
You can contact Sio Gene Therapies by phone at 833-296-8268.
Sio Gene Therapies currently employs 100-200 people.
Sio Gene Therapies's revenue is approximately < 1M.
Well-known competitors of Sio Gene Therapies include SAB BIO, UroGen Pharma, Context Therapeutics and Avalo Therapeutics.
